Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sunnybrook Health Sciences Centre
With
Eastern Cooperative Oncology Group
The Tomosynthesis Mammography Imaging Screening Trial (TMIST) LEAD-IN is being conducted to ensure that all Eastern Cooperative Oncology Group / American College of Radiology Imaging Network (ECOG/ACRIN) TMIST components are properly functional and to provide an opportunity for fine tuning before launching the full TMIST. The accrual target for TMIST LEAD-IN is 6354 participants (one tenth of the projected enrollment target for TMIST) at three lead-in study sites: 1. Sunnybrook Health Sciences Centre in Toronto, 2. Vancouver (under the auspices of the Screening Mammography Programme of British Columbia) and 3. The Ottawa Hospital.
Age
40–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Asymptomatic women age 40 and over
Scheduled for screening mammogram
Able to tolerate digital breast tomosynthesis and full-field digital mammographic imaging required by protocol
Willing and able to provide a written informed consent.
You may not be if
Presenting for mammography with symptoms of breast disease
Have new breast complaints (e.g. lump, nipple discharge)
Have had a mammogram of both breasts within the last 11 months
Previous personal history of breast cancer
Has breast enhancements (e.g. implants or injections)
